1. Home
  2. STIM vs CATX Comparison

STIM vs CATX Comparison

Compare STIM & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.26

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$0.94

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
CATX
Founded
2003
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
113.9M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
STIM
CATX
Price
$1.26
$0.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$6.00
★ $9.43
AVG Volume (30 Days)
2.3M
★ 4.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.25
N/A
EPS
★ N/A
N/A
Revenue
★ $52,776,000.00
N/A
Revenue This Year
$8.63
N/A
Revenue Next Year
$9.24
$91.56
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.78
52 Week High
$3.44
$6.16

Technical Indicators

Market Signals
Indicator
STIM
CATX
Relative Strength Index (RSI) 29.12 28.63
Support Level $1.13 N/A
Resistance Level $1.61 $2.40
Average True Range (ATR) 0.28 0.12
MACD -0.10 0.03
Stochastic Oscillator 4.59 27.35

Price Performance

Historical Comparison
STIM
CATX

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: